首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2026篇
  免费   212篇
  国内免费   9篇
耳鼻咽喉   49篇
儿科学   90篇
妇产科学   64篇
基础医学   292篇
口腔科学   86篇
临床医学   179篇
内科学   393篇
皮肤病学   29篇
神经病学   279篇
特种医学   165篇
外国民族医学   3篇
外科学   257篇
综合类   57篇
预防医学   117篇
眼科学   42篇
药学   101篇
肿瘤学   44篇
  2023年   6篇
  2022年   7篇
  2021年   22篇
  2020年   14篇
  2019年   21篇
  2018年   40篇
  2017年   19篇
  2016年   32篇
  2015年   36篇
  2014年   49篇
  2013年   71篇
  2012年   87篇
  2011年   78篇
  2010年   76篇
  2009年   69篇
  2008年   75篇
  2007年   87篇
  2006年   82篇
  2005年   80篇
  2004年   75篇
  2003年   77篇
  2002年   64篇
  2001年   48篇
  2000年   53篇
  1999年   44篇
  1998年   66篇
  1997年   68篇
  1996年   55篇
  1995年   57篇
  1994年   36篇
  1993年   38篇
  1992年   44篇
  1991年   30篇
  1990年   39篇
  1989年   45篇
  1988年   59篇
  1987年   37篇
  1986年   40篇
  1985年   45篇
  1984年   33篇
  1983年   38篇
  1982年   21篇
  1981年   24篇
  1980年   18篇
  1979年   20篇
  1978年   17篇
  1977年   18篇
  1976年   16篇
  1975年   10篇
  1974年   15篇
排序方式: 共有2247条查询结果,搜索用时 15 毫秒
31.
32.
33.
ObjectiveTo examine the effect of older versus younger age on change in anthropometric and metabolic measures during extended treatment of psychotic depression with sertraline plus olanzapine.MethodsTwo hundred and sixty-nine men and women aged 18–85 years with an episode of psychotic depression were treated with open-label sertraline plus olanzapine for up to 12 weeks. Participants who remained in remission following an 8-week stabilization phase were eligible to participate in a 36-week randomized controlled trial (RCT) that compared the efficacy and tolerability of sertraline plus olanzapine with sertraline plus placebo. Weight, waist circumference and plasma lipids, glucose, HbA1c, and insulin were measured at regular intervals during the acute, stabilization and randomized phases of the study. Linear mixed models were used to analyze the trajectories of anthropometric and metabolic measures.ResultsParticipants aged 60 years or older experienced less weight gain and less increase in cholesterol during the combined acute and stabilization phases of the study compared with those aged 18–59 years. At the acute-stabilization termination visit, mean weight in older participants was 6.5 lb. less than premorbid weight, whereas it was 17.9 lb. more than premorbid weight in younger participants. In the RCT, there was a significant interaction of treatment and age group for the trajectory of weight, but the post hoc tests that compared age groups within each treatment arm were not statistically significant. There were no clinically significant differences between younger and older participants in glycemic measures.ConclusionOlder patients with psychotic depression experienced less increase in weight and total cholesterol than their younger counterparts during acute and stabilization treatment with sertraline plus olanzapine. In the older group, weight gained during the acute and stabilization phases appeared to be partial restoration of weight lost during the index episode of depression, whereas weight gain in younger participants was not.  相似文献   
34.
35.
36.
37.
38.
Tic severity is composed of several dimensions. Tic frequency and intensity are two such dimensions, but little empirical data exist regarding their relative contributions to functional impairment in those with chronic tic disorders (CTD). The present study examined the relative contributions of these dimensions in predicting tic-related impairment across several psychosocial domains. Using data collected from parents of youth with CTD, multivariate regression analyses revealed that both tic frequency and intensity predicted tic-related impairment in several areas; including family and peer relationships, school interference, and social endeavors, even when controlling for the presence of comorbid anxiety symptoms and Attention Deficit Hyperactivity Disorder diagnostic status. Results showed that tic intensity predicted more variance across more domains than tic frequency.  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号